SCHEMBL4178193

SCHEMBL4178193

N#C/C(=C/c1ccc(F)cc1Cl)S(=O)(=O)Cc1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.41
GABRG2 P18507 2/20 0.41
GABRB3 P28472 2/20 0.41
LMNA P02545 2/20 0.41
BRAF P15056 1/20 0.41
EGFR P00533 2/20 0.39
ERBB2 P04626 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
CA4 P22748 1/20 0.38
CA7 P43166 1/20 0.38
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
MAPT P10636 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4178196 1.00 GABRA1 (0.41) GABRA1GABRG2GABRB3LMNABRAF
SCHEMBL4178190 1.00 GABRA1 (0.41) GABRA1GABRG2GABRB3LMNABRAF
SCHEMBL4184784 0.93 GABRA1 (0.47) GABRA1GABRG2GABRB3LMNABRAF
SCHEMBL4184782 0.93 GABRA1 (0.47) GABRA1GABRG2GABRB3LMNABRAF
SCHEMBL4184775 0.93 GABRA1 (0.47) GABRA1GABRG2GABRB3LMNABRAF
SCHEMBL4177125 0.90 GABRA1 (0.51) GABRA1GABRG2GABRB3LMNACA1
SCHEMBL4177121 0.90 GABRA1 (0.51) GABRA1GABRG2GABRB3LMNACA1
SCHEMBL4177127 0.90 GABRA1 (0.51) GABRA1GABRG2GABRB3LMNACA1
SCHEMBL4185233 0.88 KMT2A (0.45) LMNAEGFRERBB2CA1CA2
SCHEMBL4185236 0.88 KMT2A (0.45) LMNAEGFRERBB2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US claimed
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 GABRA1 1079/4885GABRG2 374/4885GABRB3 2714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.